Natreon to Present initial positive results on two clinical trials on PrimaVie® and Sensoril®

FOR IMMEDIATE RELEASE: June 7, 2018

Natreon Inc.
2-D Janine Place
New Brunscwick, NJ 08901
732-296-1080

Natreon to Present initial positive results on two clinical trials on PrimaVie® and Sensoril® at the ISSN Sports Nutrition Conference

New Brunswick, NJ; June 7, 2018 – Natreon, Inc., an innovative ingredient supplier known for its patented ingredients derived from nature, will share results from their latest clinical studies at the International Society of Sports Nutrition (ISSN) 15th Annual Conference and Expo, which is held from June 7 to 9, 2018 in Clearwater Beach, FL. Dr. Tim N. Ziegenfuss, CEO from The Center for Applied Health Sciences (CAHS) will present preliminary data on Natreon’s patented Sensoril (ashwagandha) ingredient titled “Effect of Sensoril® on Strength Training Adaptations, Body Composition, Muscular Performance and Recovery: the STAR Trial.”

This randomized, double-blind, parallel-group, placebo controlled clinical trial studied the effects of different doses of Sensoril® on the sports performance of 66 healthy and recreationally active male participants aged of 18 to 45. Initial results found significant improvements in the Sensoril® group for numerous sports performance measures, including 1-repetition measure squat, peak power bench, peak power squat and repetitions-to-failure on the bench press. It also showed an improvement in subjects’ perceived recovery score. Continue Reading

 

Full Press Release

Recent Posts